Valuation: Certara, Inc.

Market Cap 1.24B 1.08B 1.01B 922M 1.74B 118B 1.76B 11.79B 4.63B 59.02B 4.66B 4.56B 196B P/E 2026 *
-39.4x
P/E 2027 * 868x
Enterprise Value 1.3B 1.12B 1.05B 963M 1.82B 123B 1.84B 12.32B 4.83B 61.68B 4.87B 4.76B 205B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.11x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day+1.17%
1 week+0.43%
Current month+0.43%
1 month+13.46%
3 months+28.92%
6 months+13.46%
Current year-7.66%
1 week 6.33
Extreme 6.332
8.39
1 month 6.33
Extreme 6.332
8.39
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 31/12/2025
Director of Finance/CFO 53 14/07/2026
Chief Tech/Sci/R&D Officer - 30/07/2025
Director TitleAgeSince
Chairman 72 30/11/2021
Director/Board Member 68 31/12/2012
Director/Board Member 59 31/07/2017
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
11/05/26 Issuer sale

Executive/Senior Manager

-599,657 0.3911%
01/04/26 Fiscal year

Head of Human Resources

22,590 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%+0.43%-27.75%-55.81% 1.24B
+0.81%+8.10%-3.55%+52.18% 3,712B
+9.64%+37.43%-7.18%+840.11% 375B
+1.92%+1.21%-2.88%+48.05% 93.2B
+3.96%-11.17%+74.55%+123.94% 81.62B
+2.01%+6.09%-33.51%-7.11% 77.74B
+1.74%+5.82%-24.12%+92.98% 67.99B
+3.29%-2.05%+5.06%+68.54% 43.47B
+2.85%+11.47%-18.96%-40.93% 33.15B
+3.94%+9.45%+46.86%+53.15% 29.7B
Average +3.12%+5.25%+0.85%+117.51% 451.45B
Weighted average by Cap. +1.72%+11.19%-2.95%+117.83%

Financials

2026 *2027 *
Net sales 379M 329M 308M 281M 531M 36.06B 538M 3.6B 1.41B 18.02B 1.42B 1.39B 59.97B 391M 340M 318M 291M 549M 37.29B 557M 3.72B 1.46B 18.63B 1.47B 1.44B 62.02B
Net income -30.56M -26.52M -24.83M -22.72M -42.89M -2.91B -43.45M -291M -114M -1.45B -115M -112M -4.84B 3.62M 3.14M 2.94M 2.69M 5.08M 345M 5.14M 34.39M 13.5M 172M 13.58M 13.29M 573M
Net Debt 55.8M 48.43M 45.35M 41.48M 78.31M 5.32B 79.33M 530M 208M 2.66B 210M 205M 8.84B -23.11M -20.06M -18.78M -17.18M -32.43M -2.2B -32.86M -220M -86.23M -1.1B -86.78M -84.9M -3.66B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
07/08/26 US$8.130 0.00% 184,043
06/08/26 US$8.130 +1.50% 5,787,548
05/08/26 US$8.010 +2.69% 3,410,090
04/08/26 US$7.800 -4.65% 10,801,617
03/08/26 US$8.180 +0.99% 3,669,245
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
8.130USD
Average target price
8.040USD
Spread / Average Target
-1.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock